Reply to thread

Message: <blockquote data-quote="imhotep" data-source="post: 26799044" data-attributes="member: 562115">Last February Hungary became the first EU country to use Sinopharm. They purchased 5 million doses while it wasn't approved by the EMA. The in fact they cited an excuse, that the Chinese had the virus for the longest and thus they will know the most.Hungary has the highest per capita deaths after Peru and hence they studied 13,524 people who were at least 60 years old. More than half had been inoculated with Sinopharm.The results showed that 25.9% of those people didn’t have the minimum antibody level of 50 AU per milliliter, compared with 3.2% for those who received Russia’s Sputnik V, 1.6% for Pfizer-BioNtech and 1.1% for Moderna.Sinopharm’s ability to generate antibodies got progressively worse with age, with vaccinated people who didn’t have the minimum antibody level rising to 34.5% among those aged 80 and over, the results showed.PS: This study wasn't done by me and I have no part in it.... any concerns please copy to the team at Sri J who did the local study to find where the discrepancy is. <img src="/styles/default/xenforo/smilies/default/yes.gif"  class="smilie" loading="lazy" alt=":yes:" title="Yes    :yes:" data-shortname=":yes:" /></blockquote>

Top Bottom